ROARABLE
FREE $100K
My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Technology / HSTM / news
TRIP (49) VNET (43) SIFY (48) TBLA (56) ⌘ Pro Terminal →

Why HSTM Stock surged +2.61% Today — RQD Quant Desk Flash

$34.58 +2.61% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $34.68

HealthStream Inc. (HSTM) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $1.03B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HSTM Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HSTM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, HealthStream Inc. (NASDAQ: HSTM) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 66/100 at a spot price of $34.58 (+2.61% 1D, market cap $1.03B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 14/20, and Executive Insider Alignment 11/20. Across 715 tracked Technology issuers, HSTM ranks #132 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HSTM compare to TRIP and VNET in the Technology sector?
▼

Within the Technology sector (Computer Software: Programming Data Processing), HSTM carries a Roarable C+ (66/100 RQD), trailing P/E of 56.4x, gross margin of —, and ROIC of 5.0%. By comparison, TRIP (TripAdvisor Inc.) holds a D grade (49/100 RQD, P/E 27.0x, ROIC 13.0%, cap $1.08B) and VNET (VNET Group Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC 85.0%, cap $917.1M). Among the 5-stock peer group, TBLA leads on earnings multiple (21.0x) while VNET leads on capital efficiency (85.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HSTM?
▼

Per HSTM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001095565), HealthStream Inc. generated $304.1M in revenue (+4.3% YoY), $18.3M in net income, and $59.6M in free cash flow against $520.4M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Priced at 56x earnings—high expectations leave less room for a lukewarm quarter. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $34.68 (+0.28%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 19.6% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 66/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.4% avg 90D alpha vs SPY • 56.0% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C+
025507510066
Quant Analyst Panel Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw C · Rk C+
Cash (13)Whales (15)SEC (13)Macro (14)CEO (11)
Each axis scored 0–20
12M PRICE TARGET CONE+3.6% Base Target
$42 Bull$36 Base$28 Bear
📬 FREE HSTM RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HSTM)Realized 20D OHLCV Swing Band: ±5.2%
Deterministic 5-Pillar Attribution (66/100 Composite)
🔍 WHY HSTM SCORES 66/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (23% of score)

20D Institutional Volume Accumulation (±5.2% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+14/20 pts (21% of score)

FRED Regime × Technicals: 94% of 52W Range • RSI-14 at 59.7 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution11/20 pts (-9 pt drag)

Cannibal Buyback (-0.96% YoY Shares) & executive Form 4 sales trim 9 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
58
Grade C$33.75+0.1% Next Q
Q2 (-2Q)
61
Grade C$33.77+1.2% Next Q
Q3 (-1Q)
63
Grade C+$34.18+1.2% Next Q
Current
66
Grade C+$34.58+1.4% Hist 90D α
Trajectory: C (58) → C+ (66)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HSTM Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 66/100 (C+) score, HSTM faces multiple-compression risk if 56.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Priced at 56x earnings—high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($31.14) or 200D SMA ($25.70) invalidates the momentum regime and cuts Target Base ($35.82) toward Bear Floor ($27.94).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HSTM• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “HSTM Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
YES 66%NO 34%Trade / Inspect Odds →
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why HSTM Stock surged +2.61% Today — RQD Quant Desk Flash

HealthStream Inc. (HSTM) surged +2.61% to $34.58, trading at 94% of its 52-week range ($19.5 – $35.61). Solid steady margins (5% return on capital), mixed timing at 56x P/E—hold if owned, no rush to chase.

  • ▸Technical Tape: Trading at 94% of its 52-week range ($19.5 – $35.61) with RSI-14 at 59.7 (BULLISH MOMENTUM).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±5.2% around $34.58 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable C+ (Hold) backed by 52% gross margin and $59.6M annual free cash flow.
Live HSTM Headlines & Catalysts
MARKET WIREYahoo • 2d ago
Our Pick Of The Best AI Healthcare Stocks In November 2026

Tech giants are pouring an estimated US$828b into AI infrastructure in 2026, and a chunk of that horsepower is already flowing into healthcare. When that much capital chases one idea, the risk is ignoring where it quietl

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (HSTM Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
HSTM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +62.73%▲ ASCENDING CHANNEL
2026-11-03O $33.80H $34.58L $33.70C $34.58VOL 151.7K
RES: $36.04SUP: $30.38SMA50: $31.14SMA200: $25.70
$36.68$32.25$27.82$23.39$18.97RES $36.04SUP $30.38$34.582026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HSTM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HSTM Butterfly Map → + Track HSTM →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
39.7%/yr Implied 5Y Growth

vs. +4.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on HSTM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HSTM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HSTM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HSTM)

Technology Rank #132 of 715 ⚔️ TRIP vs HSTM Full Matrix →

1. Head-to-Head Technology Peer Comparison (HSTM vs. TRIP, VNET, SIFY, TBLA)

Industry: Computer Software: Programming Data Processing (72 Tracked Issuers)

Across 715 tracked Technology securities in the Roarable RQD universe, HealthStream Inc. (HSTM) ranks #132 by composite RQD confidence (66/100, grade C+) and #351 by equity capitalization ($1.03B). Within this direct 5-issuer industry benchmark cohort, TBLA leads on earnings valuation at 21.0x trailing P/E, while VNET leads on capital efficiency and profitability with 85.0% ROIC and — gross margin. HSTM currently leads its immediate peer cohort in composite quantitative strength at 66/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HSTM ACTIVE
HealthStream Inc.
C+ 66/100 56.4x — 5.0% +2.61% $1.03B Benchmark Subject
TRIP
TripAdvisor Inc.
D 49/100 27.0x 92.3% 13.0% +2.39% $1.08B /trip-vs-hstm →
VNET
VNET Group Inc.
D- 43/100 — — 85.0% -6.83% $917.1M /vnet-vs-hstm →
SIFY
Sify Technologies Limited
D 48/100 — — — +2.73% $901.1M /sify-vs-hstm →
TBLA
Taboola.com Ltd.
D+ 56/100 21.0x 29.8% 3.9% -1.01% $873.6M /tbla-vs-hstm →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001095565 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), HealthStream Inc. (HSTM) reported GAAP revenue of $304.1M (+4.3% vs. FY2024 revenue of $291.6M , and +9.0% cumulative change since FY2023) , GAAP net income of $18.3M, operating cash flow of $63.3M, and free cash flow of $59.6M (+6.0% YoY). On the balance sheet, HSTM closed FY2025 with $520.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $304.1M $18.3M $63.3M $59.6M $520.4M —
FY2024 (FY) 2024-12-31 $291.6M $20.0M $57.7M $56.3M $510.8M —
FY2023 (FY) 2023-12-31 $279.1M $15.2M $64.0M $64.0M — —

3. HSTM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HSTM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, HealthStream Inc. (NASDAQ: HSTM) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 66/100 at a spot price of $34.58 (+2.61% 1D, market cap $1.03B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 14/20, and Executive Insider Alignment 11/20. Across 715 tracked Technology issuers, HSTM ranks #132 in composite RQD confidence.

How does HSTM compare to TRIP and VNET in the Technology sector?

Within the Technology sector (Computer Software: Programming Data Processing), HSTM carries a Roarable C+ (66/100 RQD), trailing P/E of 56.4x, gross margin of —, and ROIC of 5.0%. By comparison, TRIP (TripAdvisor Inc.) holds a D grade (49/100 RQD, P/E 27.0x, ROIC 13.0%, cap $1.08B) and VNET (VNET Group Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC 85.0%, cap $917.1M). Among the 5-stock peer group, TBLA leads on earnings multiple (21.0x) while VNET leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HSTM?

Per HSTM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001095565), HealthStream Inc. generated $304.1M in revenue (+4.3% YoY), $18.3M in net income, and $59.6M in free cash flow against $520.4M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Priced at 56x earnings—high expectations leave less room for a lukewarm quarter. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HSTM trading relative to its 50-day, 200-day, and 52-week technical levels?

HSTM last traded at $34.58 (+2.61% on volume of 282,087 shares), positioning the stock +11.05% above its 50-day simple moving average ($31.14) and +34.55% above its 200-day simple moving average ($25.70). Across its 52-week range of $19.50 to $35.61, HSTM sits at the 93.6% percentile with a 14-day RSI of 59.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±5.2% ($32.78 to $36.38).

Direct Sub-Reports: HSTM RQD Cockpit HSTM 12M Forecast HSTM Earnings & Move HSTM Dividends & DRIP HSTM Insiders & 13F HSTM Whale Options HSTM Profit Sankey HSTM News & Why
ROARABLE RATING BRIEF • RQD 66/100 (C+) ✓ SEC XBRL & RQD VERIFIED

HSTM — HealthStream Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

HealthStream Inc. (HSTM) earns a live Roarable RQD composite score of 66/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $34.58 (+2.61% 1D, market capitalization $1.03B).

  • Fundamental Cash Engine (13/20): Anchored by return on invested capital (ROIC) of 5.0%, gross margin of —, operating margin of 6.7%, and free cash flow yield of 5.77%.
  • Whale 13F & Options Flow (15/20) + Insider Conviction (11/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (14/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 5/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

HealthStream Inc. (HSTM) is a NASDAQ-listed issuer classified under the Technology sector and the Computer Software: Programming Data Processing industry..0B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), HealthStream Inc. (HSTM) reported $304.1M in annual revenue (up from $291.6M in FY2024, +4.3% YoY) and $18.3M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($279.1M revenue, $15.2M net income) through FY2025, HSTM scaled operating cash flow to $63.3M and free cash flow to $59.6M, backed by $520.4M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (C+ • RQD 66/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of 5.77% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 13/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $19.50 – $35.61 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Priced at 56x earnings—high expectations leave less room for a lukewarm quarter. Investors must weigh 56.4x trailing P/E and 42.7x EV/EBITDA against 6.7% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

No upstream or downstream dependencies, sector correlations, or bottlenecks are documented in the source. Watchpoints limited to the source: the sector classification (Technology / Computer Software) and the Copeland position reduction flagged in the news wire.

  • Key Question #1: Can HSTM sustain or expand its 6.7% operating margin and 5.0% ROIC against Computer Software: Programming Data Processing peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $304.1M and free cash flow of $59.6M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is HSTM's 52.5x forward P/E multiple to Technology capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

HSTM Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for HealthStream Inc. (HSTM) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to HSTM Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HSTM Bull vs. Bear Conversation Board — What's Your Call at $34.58?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HSTM 🐻 33% BEARISH CONVICTION
1. Pick Your Side on HSTM:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH 🎯 Target: $44.48 (+32.0%)
📌 Pinned Debate

Revenue grew each reported year from $279.1M to $304.1M while FCF yield of 5.77% and an upper-neutral RQD score of 67 keep the stock on

Long HSTM at $33.70 targeting $44.48. Revenue grew each reported year from $279.1M to $304.1M while FCF yield of 5.77% and an upper-neutral RQD score of 67 keep the stock on watch for breakout.. Institutional whale score is 15/20 and the risk/reward vs. the $19.50 52-week low is skewed heavily in favor of bulls.

ArenaChamp_24 🐂 BULL

@CashFlowKing Agree on the RQD 66/100 quality, though with 1.0 beta I'm scaling in with half-size at $33.70 and keeping dry powder in case we test $31.34.

FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH 🎯 Target: $27.97 (-17.0%)
Spot @ $33.70

A P/E (TTM) of 56.4 and EV/EBITDA of 42.7 sit far above a ROIC of 5%, and net income fell from $20.0M to $18.3M in FY 2025 while Copela

I respect the product at HealthStream Inc., but the stock at $33.70 is a different story. A P/E (TTM) of 56.4 and EV/EBITDA of 42.7 sit far above a ROIC of 5%, and net income fell from $20.0M to $18.3M in FY 2025 while Copeland Capital cut its position.. FCF yield is 5.77% and RQD sits at 66/100 (C+) — why pay up here when you can wait for next quarter's numbers?

LIVE TAPE